Clinical Trials Directory

Trials / Completed

CompletedNCT04260048

Impact of Hypothalamic Gliosis on Appetite Regulation and Obesity Risk in Children

Status
Completed
Phase
Study type
Observational
Enrollment
101 (actual)
Sponsor
University of Washington · Academic / Other
Sex
All
Age
9 Years – 11 Years
Healthy volunteers
Accepted

Summary

BEAM is a multi-site longitudinal cohort study of hypothalamic gliosis, central regulation of appetite and weight gain in children. Participants will be recruited from the community in the greater Seattle and greater Baltimore area. All participants will consent to enroll in the 24-month study during which they will complete 5 in-person study visits.

Detailed description

The proposed 2-site research study uses a longitudinal cohort design in 102 children aged 9-11 yr. It will include for all participants baseline MRI and functional MRI, in-depth eating behavior testing, and measurement of hormone profiles. Serial measurement of weight and self-reported eating habits will occur over 2 yr, with a repeated MRI at 2 yr. The study aims to: 1) test if MBH gliosis is associated with impaired intake regulation and poor weight outcomes over 2 yr in children, 2) determine if CNS appetitive processing is negatively affected when evidence of MBH gliosis is present, and 3) test for other brain regions in which gliosis is present in association with excess adiposity in children. An exploratory aim will assess changes in gliosis in children over 2 yr and their relation to changes in body weight and adiposity.

Conditions

Timeline

Start date
2020-02-21
Primary completion
2024-03-28
Completion
2024-05-30
First posted
2020-02-07
Last updated
2025-05-25

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT04260048. Inclusion in this directory is not an endorsement.

Impact of Hypothalamic Gliosis on Appetite Regulation and Obesity Risk in Children (NCT04260048) · Clinical Trials Directory